{"ticker": {"uuid": "0e416c83-3dab-4754-b10c-b5b5dbf3cf42", "symbol": "KVUE", "name": "Kenvue Inc.", "exchange": "NYSE", "country": "US", "sector": "Consumer Defensive", "industry": "Household & Personal Products"}, "articles": [{"title": "Diversify Wealth Management LLC Buys New Stake in Kenvue Inc. $KVUE", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNSU15NzZzZWVROHp0TUtORk93VTVXSDRMZHB2LWRCaEhjT3ZfZEZ0QlY4SjNvWW4zSTlZcU1QUElRdG12RjVqRWRSVkRZdE9QbEM4aG40QWpnZm5hb0FlWDR4cmxaYzMzTnZndW1RR3FpSjAtT2FIa1NYZWlQWUszNzc5dFZnQ0prSVJraEtoU21abmZyQ1oxUEVfdTA5ZmhCYjhmcG5sc3d3SFl6NVd1dThVTDBDd3dKR0I3eVBkdllZRUps?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T08:07:39+00:00", "published_display": "16 Jul 2026 08:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Blackhawk Capital Partners LLC Invests $1.66 Million in Kenvue Inc. $KVUE", "summary": "Blackhawk Capital Partners LLC has acquired a new stake in Kenvue Inc., purchasing 96,412 shares valued at approximately $1.66 million during the first quarter. Despite high institutional ownership and Kenvue beating recent earnings and revenue estimates, analyst sentiment remain", "url": "https://www.marketbeat.com/instant-alerts/filing-blackhawk-capital-partners-llc-invests-166-million-in-kenvue-inc-kvue-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T07:49:28", "published_display": "16 Jul 2026 07:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fifth Third Bancorp Grows Position in Kenvue Inc. $KVUE", "summary": "Fifth Third Bancorp significantly increased its stake in Kenvue Inc. by 167.3% in Q1 2026, holding over 600,000 shares valued at approximately $10.4 million. Kenvue reported strong quarterly results, exceeding EPS and revenue expectations, and offers a 4.4% dividend yield, though", "url": "https://www.marketbeat.com/instant-alerts/filing-fifth-third-bancorp-grows-position-in-kenvue-inc-kvue-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T07:40:48", "published_display": "15 Jul 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Inc. stock falls Tuesday, underperforms market", "summary": "Kenvue Inc. (KVUE) shares fell by 2.44% on Tuesday, closing at $18.76. This decline occurred during a generally positive trading session where the S&P 500 Index and the Dow Jones Industrial Average both saw gains. This marks the second consecutive day of losses for Kenvue stock.", "url": "https://www.marketwatch.com/data-news/kenvue-inc-stock-falls-tuesday-underperforms-market-fc9b75ac-6aa87091cde2", "source_name": "MarketWatch", "published_at": "2026-07-14T16:54:00", "published_display": "14 Jul 2026 16:54", "sentiment": "negative", "sentiment_pct": 20, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Faces Fresh Tylenol Lawsuit Risk On A Valuation Question", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T14:38:01+00:00", "published_display": "14 Jul 2026 14:38", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calamos Advisors LLC Acquires 651,000 Shares of Kenvue Inc. $KVUE", "summary": "Calamos Advisors LLC significantly increased its stake in Kenvue Inc. (NYSE:KVUE) during the first quarter of 2026, acquiring an additional 651,000 shares to bring its total to 3.351 million shares valued at approximately $57.8 million. This acquisition follows Kenvue's better-th", "url": "https://www.marketbeat.com/instant-alerts/filing-calamos-advisors-llc-acquires-651000-shares-of-kenvue-inc-kvue-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T08:23:35", "published_display": "14 Jul 2026 08:23", "sentiment": "positive", "sentiment_pct": 63, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Shares Surge After Favorable Court Ruling", "summary": "Kenvue (KVUE) shares rose 5% after a favorable court ruling excluded plaintiffs' expert opinions in a class action lawsuit linking prenatal Tylenol to autism or ADHD. The company plans to seek dismissal of the lawsuits, which could push its stock price to between $23 and $25 per ", "url": "https://www.gurufocus.com/news/8955790/kenvue-kvue-shares-surge-after-favorable-court-ruling?mobile=true%3Fmobile%3Dtrue&mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-14T02:40:35", "published_display": "14 Jul 2026 02:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue options trading climbs to over 16,000 contracts By Investing.com", "summary": "Options trading activity for Kenvue Inc. (KVUE) significantly increased to 16,298 contracts by 11:50 a.m. New York time on Monday. Call options comprised 7,912 contracts, while put options totaled 8,386 contracts. The most active contracts included the July 17, 2026 $19 put and t", "url": "https://au.investing.com/news/stock-market-news/kenvue-options-trading-climbs-to-over-16000-contracts-93CH-4530470", "source_name": "Investing.com Australia", "published_at": "2026-07-14T02:04:00", "published_display": "14 Jul 2026 02:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Second Circuit Court of Appeals Ruling", "summary": "Kenvue Brands LLC, the maker of Tylenol, issued a statement regarding a Second Circuit Court of Appeals procedural ruling on acetaminophen litigation. The company emphasized that independent science shows no proven link between acetaminophen use and autism or ADHD, and highlighte", "url": "https://www.kenvue.com/media/second-circuit-court-of-appeals-ruling", "source_name": "Kenvue", "published_at": "2026-07-13T19:20:23", "published_display": "13 Jul 2026 19:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue's Tylenol Liability Nightmare: Appeals Court Reversal Ignites Fresh Legal Battle", "summary": "A federal appeals court has reinstated hundreds of lawsuits alleging a link between prenatal Tylenol exposure and autism/ADHD, overturning a previous dismissal. This creates significant financial and reputational uncertainty for Kenvue, despite the company's insistence on Tylenol", "url": "https://www.kavout.com/market-lens/kenvue-s-tylenol-liability-nightmare-appeals-court-reversal-ignites-fresh-legal-battle", "source_name": "Kavout | AI", "published_at": "2026-07-13T18:38:13", "published_display": "13 Jul 2026 18:38", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims", "summary": "A federal appeals court has revived over 500 lawsuits against Kenvue, the maker of Tylenol, concerning claims that the painkiller causes autism and ADHD in children when used during pregnancy. The court stated that a district judge improperly excluded expert testimony from three ", "url": "https://www.theglobeandmail.com/business/international-business/us-business/article-us-appeals-court-kenvue-lawsuits-tylenol-autism-claims/", "source_name": "The Globe and Mail", "published_at": "2026-07-13T17:52:28", "published_display": "13 Jul 2026 17:52", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Update: Kenvue Must Face Claims Linking Tylenol to Autism, Appeals Court Says", "summary": "A federal appeals court has ruled that Kenvue, the maker of Tylenol, must face claims in multidistrict litigation alleging a link between prenatal acetaminophen use and autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD). This decision overturns an e", "url": "https://www.moomoo.com/news/post/72874211/update-kenvue-must-face-claims-linking-tylenol-to-autism-appeals?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-13T17:38:35", "published_display": "13 Jul 2026 17:38", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KVUE Stock Dips After Court Revives Tylenol Autism Lawsuits", "summary": "Kenvue (KVUE) shares dropped after a federal appeals court revived lawsuits alleging Tylenol use during pregnancy increases the risk of autism and ADHD in children. The court overturned parts of a lower court's dismissal, allowing key expert testimonies, though Kenvue maintains e", "url": "https://stocktwits.com/news-articles/markets/equity/kvue-stock-dips-after-court-revives-tylenol-autism-lawsuits/cZmzDliR7Yj", "source_name": "Stocktwits", "published_at": "2026-07-13T17:09:14", "published_display": "13 Jul 2026 17:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Inc. stock falls Monday, underperforms market", "summary": "Kenvue Inc. stock (KVUE) fell 1.28% on Monday, closing at $19.23, which was below the market's performance as both the S&P 500 Index and Dow Jones Industrial Average also declined. The company's stock is now 15.92% below its 52-week high of $22.87.", "url": "https://www.marketwatch.com/data-news/kenvue-inc-stock-falls-monday-underperforms-market-62ffe00f-e973b36d569d", "source_name": "MarketWatch", "published_at": "2026-07-13T16:55:00", "published_display": "13 Jul 2026 16:55", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Must Face Claims Linking Tylenol to Autism, Appeals Court Says", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kenvue-must-face-claims-linking-154201709.html", "source_name": "MT Newswires", "published_at": "2026-07-13T15:42:01+00:00", "published_display": "13 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Inc. (KVUE) Stock Price | Live Quotes & Charts | NYSE", "summary": "This page provides live quotes and charts for Kenvue Inc. (KVUE) stock, including its current price and daily performance. It also includes sections for analyst ratings and earnings information, although specific data for Kenvue Inc. is noted as unavailable. The page is part of a", "url": "https://www.timothysykes.com/quote/KVUE/", "source_name": "www.timothysykes.com", "published_at": "2026-07-13T15:38:22", "published_display": "13 Jul 2026 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US appeals court revives private lawsuits linking Tylenol to autism, ADHD", "summary": "A federal appeals court has revived over 500 private lawsuits against Tylenol maker Kenvue, alleging a link between Tylenol use during pregnancy and autism and ADHD in children. The 2nd U.S. Circuit Court of Appeals in Manhattan ruled that a district court judge improperly exclud", "url": "https://www.reuters.com/world/us-appeals-court-revives-private-lawsuits-linking-tylenol-autism-adhd-2026-07-13/", "source_name": "Reuters", "published_at": "2026-07-13T15:38:21", "published_display": "13 Jul 2026 15:38", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock falls after court revives autism lawsuits", "summary": "Kenvue Inc. shares fell 1% after a federal appeals court revived lawsuits alleging Tylenol causes autism in children whose mothers used it during pregnancy. The court overruled a lower court's decision to block cases by excluding expert testimony, remanding it for further proceed", "url": "https://www.investing.com/news/stock-market-news/kenvue-stock-falls-after-court-revives-autism-lawsuits-93CH-4788913", "source_name": "Investing.com", "published_at": "2026-07-13T15:30:21", "published_display": "13 Jul 2026 15:30", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tylenol-Maker Kenvue Must Face Autism Claims, Appeals Court Says", "summary": "A federal appeals court has reinstated lawsuits against Kenvue Inc., the maker of Tylenol, alleging the company concealed risks that the pain reliever could cause autism in children when taken by pregnant mothers. The court ruled that a lower court improperly dismissed the cases ", "url": "https://www.bloomberg.com/news/articles/2026-07-13/tylenol-maker-kenvue-must-face-autism-claims-appeals-court-says?srnd=homepage-europe", "source_name": "Bloomberg", "published_at": "2026-07-13T15:20:00", "published_display": "13 Jul 2026 15:20", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue options trading climbs to over 16,000 contracts", "summary": "Options trading activity for Kenvue Inc. (NYSE:KVUE) surpassed 16,000 contracts by Monday morning, with a near-even split between call and put options. Key activity included the July 17, 2026 $19 put and the July 17, 2026 $20 call, as well as several spread strategies and straddl", "url": "https://www.investing.com/news/stock-market-news/kenvue-options-trading-climbs-to-over-16000-contracts-93CH-4788970", "source_name": "Investing.com", "published_at": "2026-07-13T12:03:00", "published_display": "13 Jul 2026 12:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Listerine Cool Mint by Kenvue Inc. - mouthwash staple under fresh brand owner", "summary": "This article examines Listerine Cool Mint, a flagship product now under Kenvue Inc., detailing its formula, market positioning within the Listerine range, and its transition from Johnson & Johnson. It highlights the mouthwash's contribution to Kenvue's stable revenue stream, cons", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/listerine-cool-mint-by-kenvue-inc-mouthwash-staple-under-fresh-brand/69760042", "source_name": "ad-hoc-news.de", "published_at": "2026-07-13T11:24:21", "published_display": "13 Jul 2026 11:24", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock steadies as investors weigh its consumer brands", "summary": "Kenvue, the maker of Tylenol and other consumer health products, is categorized as a consumer staples company, leading to a more defensive investor profile. The company's diverse portfolio across pain relief, skin health, oral care, and allergy relief means its stock performance ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/kenvue-stock-steadies-as-investors-weigh-its-consumer-brands/69758889", "source_name": "Ad Hoc News", "published_at": "2026-07-13T07:48:23", "published_display": "13 Jul 2026 07:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (NYSE:KVUE) Rating Increased to Buy at Wall Street Zen", "summary": "Kenvue (NYSE:KVUE) has received an upgrade to a \"buy\" rating from Wall Street Zen, though the overall analyst consensus remains a \"Hold\" with an average price target of $19.33. The company's shares are currently trading at $19.50, and its recent earnings exceeded expectations wit", "url": "https://www.marketbeat.com/instant-alerts/kenvue-nysekvue-rating-increased-to-buy-at-wall-street-zen-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T17:33:04", "published_display": "12 Jul 2026 17:33", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Reactions to KVUE Trends in Macro Strategies", "summary": "The article provides a technical analysis of Kenvue Inc. (NASDAQ: KVUE), highlighting conflicting sentiment and suggesting choppy market conditions. It outlines three AI-generated trading strategies\u2014Position, Momentum Breakout, and Risk Hedging\u2014tailored for different risk profile", "url": "https://news.stocktradersdaily.com/news_release/151/Technical_Reactions_to_KVUE_Trends_in_Macro_Strategies_071126105601_1783824962.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-11T23:08:10", "published_display": "11 Jul 2026 23:08", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitomo Mitsui Trust Group Inc. Sells 343,749 Shares of Kenvue Inc. $KVUE", "summary": "Sumitomo Mitsui Trust Group Inc. reduced its stake in Kenvue Inc. by 6.6% in the first quarter, selling 343,749 shares, though it still holds over 4.8 million shares valued at $84 million. Other institutional investors showed mixed activity, with some increasing their positions a", "url": "https://www.marketbeat.com/instant-alerts/filing-sumitomo-mitsui-trust-group-inc-sells-343749-shares-of-kenvue-inc-kvue-2026-07-11/", "source_name": "MarketBeat", "published_at": "2026-07-11T14:38:07", "published_display": "11 Jul 2026 14:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Listerine Cool Mint by Kenvue Inc. - mouthwash classic backs broader oral care push", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQcWxvV3JONmxKRWVCRExvNVJpZ1ZNSkQzVnROUGtadklaZ2dxUUpXNWkwWk9VZVhlQmkzcG9hUHF0X0otVlhfOUJ5Rm5nUFpHZWhtWEhDdV8tYmRLX0Vncm91bi14aWVua0FqU3Y5Z0J4eDhfcHcwcldPRXBIcVQxQzRCV1dvVXFrSEFvamlwM2ZZQ0NsX0NiVmphS2hSTHdZNHlUQ29uM2F1NTJpeGUydU1yODF6Q1d1bkdBZ3hTTDNXajZGX1V2bQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-11T05:48:37+00:00", "published_display": "11 Jul 2026 05:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock holds steady as the consumer health story builds", "summary": "Kenvue stock, trading on the NYSE under ISIN US49177J1025, maintains stability due to its strong consumer health portfolio and well-known household brands. Spun off from Johnson & Johnson, the company's revenue is tied to everyday health products, focusing on brand strength, pric", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/kenvue-stock-holds-steady-as-the-consumer-health-story-builds/69741445", "source_name": "ad-hoc-news.de", "published_at": "2026-07-11T06:10:06", "published_display": "11 Jul 2026 06:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue's Hidden Bullish Bet: Options Surge Amidst Acquisition and Mixed Valuation Signals", "summary": "Kenvue (NYSE: KVUE) has shown a significant surge in bullish call options despite its stock largely underperforming the market and maintaining a \"Hold\" consensus from Wall Street analysts. This contrarian interest, combined with its ongoing integration with Kimberly-Clark and a m", "url": "https://www.kavout.com/market-lens/kenvue-s-hidden-bullish-bet-options-surge-amidst-acquisition-and-mixed-valuation-signals", "source_name": "Kavout | AI", "published_at": "2026-07-11T01:38:17", "published_display": "11 Jul 2026 01:38", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illinois Appellate Court Affirms $45 Million Mesothelioma Verdict Against Johnson & Johnson and Kenvue", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/illinois-appellate-court-affirms-45-203000724.html", "source_name": "Business Wire", "published_at": "2026-07-10T20:30:00+00:00", "published_display": "10 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue focuses on consumer health portfolio as investors track long term growth prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOS25wdzZTZFhwamRnZkpTNG91RG8zSnRUaWlGM001dDhYN1c3NUVtWjJIM1pjVWpmdjM4N0tCb243YXdhdWdFN3JCbHNLbHdpYlhPVU9yNklrWUVmeDh1MUlhY3dnOEhjZUFIenRBUm5MSHBDYk13VzdXQkNFZjJfQVJVaGdJNEtPT21PWXlNcFUyUHV2QU1NMEduU2prQVBlemdNMlFJN3hFZFdWMTZaeGpBWEU5YTNiekJnVWUwVmYzcE5SSnVkVVA4cw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-03T15:57:05+00:00", "published_display": "03 Jul 2026 15:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Stock May Be A Bargain Despite The Acquisition Bid", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNSkhCMTl5RVJkc2lzUGVsc2FGbGVXU2Z5VGpoNWRjc3FBN2dMZTNMWFV5WVhlSW1Yc0hSbGR5bU5Yb0sxUHdRNFZOX3NmWHdiVUNpY2ZNN05KZjdSaENybmNzYTF0d2xsbGEwQUNET0NmMU5hWU9FdHBFaTM3Wm9SVnZjdGtGM2c4OFFocWRNMDQtQjZrMDVLeHN3?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy Kenvue Inc. (KVUE)\u2019s Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOUXFueTFqclFBTUFOSFY4Y2NmajVsSG84V2RITEFPRzdjUjBJRWRQR1U4NGFGaXBQSUtYOHBlZ2xnRmtobU1pSkdzTDRqei1qM0poWS0tUU1Wcl9ob25oeTlIOFhfU2gwem9PbkVBalQ2U0xXbDQ0Q2JlX3d0MmxBVnBQM3E5OXczR3BfWGZxOGxvUkNV?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Faces A $48.7 Billion Kimberly Clark Deal And Big Portfolio Questions", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQR1E1dkFZY3VDRk1JbWFfWWR4UkpjX0k1WXk5alp6bTlmTndObE1NWUwwS0t2QkdHMzVUeThycW1sWW1icnFST2twTEV6SUxmN1lXVjBQRjdiLU1uLUFTbWRMZXVYMjUwcE9pYjl3QVF0Tm14MnFCX29KdlpTY1p0YjNDNzUwWVE3NXdHdFFJQVA?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Stock - Weekly outlook with earnings and events ahead", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQbmtfWXEtc2tzU2pmWGFEYW0zeGdDeXlMcjJhc0M2bDY2eVhlMHVOZnJKcXo0aUhHOWF0ZldEOTc3TlJxS0dQRW9YSmhfVElRejlhMVQ2Y2o0d0Z0T01oaThfMUNxclhyVWZQR0NQZ1Y2QzFUMVo2Z2c0R1ZBQUlSSUM4ODZHbTBHUHJIeGZNWGRnSzRTM1IzcnpPekZubjd4c25OeVk5aklpQS01NTdaZU1QVXVLM3RV?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Kenvue (KVUE) Offer Value After Share Price Decline And DCF Upside Projection", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPbWs1SG9sOVY1Rkx1RnowNXdETzg1TDh4dHJMak1wbHZHb3A3S0w4eHpsNENKZVVwdjBqdkt3dlpwZjNwT3pmZVFUSVVEVGhlWi1ETXdhOG5MZUQtWFpDbS1teTJCMFRkQ2c4Vy10cnVnS1lZVlFnZGdlNjhTNzJCRmhJSjhWVlBXNXBXemZZdmI0bVpEZDJYWA?oc=5", "source_name": "Market source", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Stronger Q1 2026 Earnings and Legal Shifts At Kenvue (KVUE) Have Changed Its Investment Story", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock (US49177J1025): Q1 growth accelerates ahead of Kimberly-Clark deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNaW0zSGI5a0NncUd2bnRxYTZ4cW5MbXV0d3BDRjJNRE1sY2tMRnpkZG9fLWlEUmE1REhjNWU4bmF1cExDMDl4TnM0Z0hXei1uSzdvUE5QaU1POGJ4X1M5Ui00ZnR5WWJVeEx4WFFnV2tuMDRvajU5bWpqMHZ6VldjYjNvVm0yeFNMaDlvZ1JtRFI5LS1KWnBFYmp1anp3Q3RlYnBYZ3FBZFhKbGoyR3ZkUFpmNktsNk0yVW5xS1VHRWxfTHhybjlXdF93?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Valuation Check After Mixed Share Price And Earnings Multiple Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQU1dCSlgwWXpHb2xfWVNrRm9MZFQ2ajYwM19WenpmWEx0Zk9iVXg1eDFmNi04b3NTRjZLaGZ6bVdxYTlUVkluc1EwX3lvNWRKbkRzOHdNSkw3cTZ6UFQ0Z0VybzhTREVtSHRPMHF1TEZWYXg5ajhEby0zVGNWZUtickNkbHNWdTFwMm1YT09OSXFNZFlQX1RaMi1KSjBPUG8?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Stock: Is Wall Street Bullish or Bearish?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQeHBiQndHejFjR3I3V2RNMEh1WnhseFkzZkdLdHZicnlUQVJWSmtwT25lcUdZTWxaRW9QZkVqcDdZQkVrNG1ieHF0eDdnek5LOW00Vkw1cmFUbVVRNGZ6aVUyZjQweDhHQmNPaVZ3VHZFcy1mMmEyeHc4ZlZNZGNxZFVVbzF4eGVsam5qTGZuV1YweXd3MVBoSXBrWWNDdw?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol safety", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPUDF0U3pNNGFzb00yR21PNkhvMFhGNnRwQUpxZ2hVQ2JlUWNmRW1WNE9zZU84NHk2V3dJTDFhM0FHdlRxdUxOQ2dYOFlSWHhhWnpiUS1leEh3RmtCX0ZqdUlkSXBsc2taVjVBMWhHVWNwZUFxQ3pSWnhuQlhMT0FMNU1COThLVHp3Mzk3X3FQaUxHd1ZXTzNQWjZubXdpbjZkWGc4?oc=5", "source_name": "Reuters", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Tops Q4 Earnings Estimates, Advances Toward Kimberly-Clark Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPN3AteHQ0ZVRSdks2NzhfYkVadzFiQWVHeWxUNUFZdHFqanBGblUteUMyX3NMSF9aX3VQejd2ME9lOUJmMkFuS2RuUkY3SnZIS3VuVGluTFM3NFNhYWVJRkdVaEFLZmZ5ZzRjU3dkYzJtbEluMlZGdnlkLU9WZEprbUIxbkgwYzlCNUY4cGhhUEhwRzVQWjdKaVRLbUd0UU92bWdqaTc0NDVnOVFYN0thZldtR1NvSkRzYXE0a29mbkl6SGM?oc=5", "source_name": "TradingView", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Reports Fourth Quarter and Full Year 2025 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOaHEzWGpiSHBmdnp3VWdCdVFlQlBvUnVVOGQ5UzR2Q013bFRWUDhVUHpiWDJ5ZUFQdkpoXzAwVmV3Z2dMSEZlZVl5akkwZ09adjZjUHloeHU5RXhiQ2J2ZTU5bG1hSEhCbXZOSjB6X3pZVngzU3pUSE9TSXFMNFlUY1NLaTBoNUJkZWMyYXRVSS14eTg1cFRXRVFmZnM5YzQ1dmVKVHZUSWEzWVczZTE4U0hxUQ?oc=5", "source_name": "Business Wire", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (NYSE: KVUE) details 2025 results, $250M restructuring and Kimberly-Clark deal progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPQ1RfbmQ2NDhuNzlQaTV5bGhkNDU4ZVpZM3hpemk1TWRjSW9BQ0ltVDVkVGRCMHpvTk5BT0IyemI2VjNIaVlMRTFTQ1NxWEwtOWpDcTdNQ2hZOE9hVXNwajIxbkNwODk4UDZvS2YxbnZvR0t5cU5UT1hhM3NVWEZnUzkyRmVKbEVRMHNMTUlfZGRmU2ZQVVQ3QXpxVkxUdUJw?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Texas judge defers ruling on Kenvue dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOOFpvVTJEYUdmTkVHMlpDTUQ1eGV6dTMwMHlDaVFzQURmQkk4QXNrVVBCOERnSFRpN3VWMHFMdmFsNzdSdFJYekFXVUJ0c0VXaVFDazlXb0JieDduSHFhRE95THVxX1dYWXh1UzYtWHB4ZDlRVlNxbkNDLUNsVUVUblRXbGNUS2hlTDFB?oc=5", "source_name": "Reuters", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxQQWctaTJQcFEzbWxDX0FLWEdjTDg2a3daMmlWaG1OeWRBRUhka1dwb0dJbHBzZk9HUHpaV3B0ZXRYZFVTc3hxOEVDdkFMZTZCY2Q3WlJ5aWJLdVpZWEVjQk95T1h1UFBfTlRlZEdOWXI2UlFlejFQOFFjT0xvQW9nbEFrS042VHo2VWZJODhVWHdIbUZNVzVWY1FBNWVGVDF2VmQwcW5zS2wwa2xGbkJiTEZOeDQ1ZFFMMHZjeW1WbVdUVVpnSTdqcEFINXR3ZjZNRFZSVVJQTmhvRmNfWVVENEduRVczZWwzMGFLTTNMQVloeU8wVXc?oc=5", "source_name": "Kenvue Investor Relations", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue\u2019s legal risks loom over planned acquisition by Kimberly-Clark", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxORVpKSjZSNlRaVEZObmhqUV9wSm93aUF5bDNNQmd0QnVzaGZUbVlwSnhtQkNZSjBLWmJ6eXNUYmlYTlZERTJfVEdBMDlKMFd5OGtlenZiT3dJNE1fSUl3dTd5dm5DOWRnSVByR0Y3b24xWDcwZkpoZ0YyRFdhNFB4SllFNVBtdXBtVVh5dEtJTjZMRV9YZEo4bTE0Q3VWMV9RcWp6ZjN2dnBna2JabmNteEt2bWpiM1Q0NXliZQ?oc=5", "source_name": "Reuters", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (NYSE:KVUE) Is Due To Pay A Dividend Of $0.2075", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-01T07:00:00+00:00", "published_display": "01 Nov 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Litigation risks for Kenvue: focus shifts to U.S. appeals court", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOdXlNQUFHeTB5NXFYczAxOWxFN1Nzdm5wM1E0MnpDdFZTT3NIUllGRWUwdFU2dVlwMUl4T2s0S25pWGhaN1BhMjRQcGpvcU5RdkZHV01HaEtPTlpFclo4VEhWZWRua2pmTU96S0xYNHJOWnZpR096dkdnc19fblUxbEk1bjNTUURHRVo2eUk3cjJxZHJ1bkcyelNzLTlCQkJETXd6Qm12Y2piZXNiWTJUUGVlUlJUdXBN?oc=5", "source_name": "Investing.com", "published_at": "2025-10-05T07:00:00+00:00", "published_display": "05 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tylenol-maker Kenvue shares bounce back, Trump claims face pushback", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPNmhEd3NpMlVhSy1xS2tPNE5uRHdvSmllRmtXU0JIT0p3cG9PWV9Vd1JjR3Z5bjRzeUZYT2ZJbjJTUFZjVU16Z2wxU0djRmlpZVVLWU5Pb3J2amNhZ3kwTU1TdE84VW9COXBxaUFrdmtRcnVUUE5VRGdhVE5SSFBLQ1hFX0s5dEY5bS1RUjNSS1p1WGM3c2JoUndqdWZFMkd3TXE1TEJ2OGNHUUZMUDdYOUFHRWJ0bEExSDVaTXJOZUlHSE02cVNzSjRvUDA1UQ?oc=5", "source_name": "Reuters", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE1HTzdmbHVxeHdNcllfQWpZdWNBaVAyZ3g3V0JZVmJ0cXBzMmFBdWVBbHJzelhCWkxsSXR4ckx0YnVzWDRRNXpBVDhFZjlVWWE3YzBWckZwcFMyTlVvbTZralZHakw0VEJIZ09RM25fcUg0cXl4WjVV?oc=5", "source_name": "The New York Times", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPR1dRTW1vdXZmcDZXc0o1bVc0NjZCRFo4M1o1aWdwdUhRTjFvYmltOUx3U05aUG9SRGdJZXBTVWJjMndRN3dIU2dRUmxidDg0UEx5VDJwQmFZQ2tvREZuckU4dDc2WnpYWVk3eUhZYU5ZUGFNdnc2c082YkViUmRjU0ZR0gGHAUFVX3lxTE1mT2V1eFVQUWRKUllOVUxIS3lKQ2ppRkxBYnhlTG5EQnJEd29iamRfYmlxZFlDbFdYR3ktbDd5MEhpT2lzVkpZY18yR2ZJLUI3ZjdhTGNzYmtSQUxENy02QUJzbHRpOWtrX1VxM2NBbjAtVzFuQXdqajcwSGtrYUpkX2Z3TUhoSQ?oc=5", "source_name": "CNBC", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Wary Of Buying Kenvue's (NYSE:KVUE) For Its Upcoming Dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-09T07:00:00+00:00", "published_display": "09 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Diversify Wealth Management LLC Buys New Stake in Kenvue Inc. $KVUE", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNSU15NzZzZWVROHp0TUtORk93VTVXSDRMZHB2LWRCaEhjT3ZfZEZ0QlY4SjNvWW4zSTlZcU1QUElRdG12RjVqRWRSVkRZdE9QbEM4aG40QWpnZm5hb0FlWDR4cmxaYzMzTnZndW1RR3FpSjAtT2FIa1NYZWlQWUszNzc5dFZnQ0prSVJraEtoU21abmZyQ1oxUEVfdTA5ZmhCYjhmcG5sc3d3SFl6NVd1dThVTDBDd3dKR0I3eVBkdllZRUps?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-16T08:07:39+00:00", "published_display": "16 Jul 2026 08:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Blackhawk Capital Partners LLC Invests $1.66 Million in Kenvue Inc. $KVUE", "summary": "Blackhawk Capital Partners LLC has acquired a new stake in Kenvue Inc., purchasing 96,412 shares valued at approximately $1.66 million during the first quarter. Despite high institutional ownership and Kenvue beating recent earnings and revenue estimates, analyst sentiment remain", "url": "https://www.marketbeat.com/instant-alerts/filing-blackhawk-capital-partners-llc-invests-166-million-in-kenvue-inc-kvue-2026-07-16/", "source_name": "MarketBeat", "published_at": "2026-07-16T07:49:28", "published_display": "16 Jul 2026 07:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fifth Third Bancorp Grows Position in Kenvue Inc. $KVUE", "summary": "Fifth Third Bancorp significantly increased its stake in Kenvue Inc. by 167.3% in Q1 2026, holding over 600,000 shares valued at approximately $10.4 million. Kenvue reported strong quarterly results, exceeding EPS and revenue expectations, and offers a 4.4% dividend yield, though", "url": "https://www.marketbeat.com/instant-alerts/filing-fifth-third-bancorp-grows-position-in-kenvue-inc-kvue-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T07:40:48", "published_display": "15 Jul 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Inc. stock falls Tuesday, underperforms market", "summary": "Kenvue Inc. (KVUE) shares fell by 2.44% on Tuesday, closing at $18.76. This decline occurred during a generally positive trading session where the S&P 500 Index and the Dow Jones Industrial Average both saw gains. This marks the second consecutive day of losses for Kenvue stock.", "url": "https://www.marketwatch.com/data-news/kenvue-inc-stock-falls-tuesday-underperforms-market-fc9b75ac-6aa87091cde2", "source_name": "MarketWatch", "published_at": "2026-07-14T16:54:00", "published_display": "14 Jul 2026 16:54", "sentiment": "negative", "sentiment_pct": 20, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Faces Fresh Tylenol Lawsuit Risk On A Valuation Question", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-14T14:38:01+00:00", "published_display": "14 Jul 2026 14:38", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calamos Advisors LLC Acquires 651,000 Shares of Kenvue Inc. $KVUE", "summary": "Calamos Advisors LLC significantly increased its stake in Kenvue Inc. (NYSE:KVUE) during the first quarter of 2026, acquiring an additional 651,000 shares to bring its total to 3.351 million shares valued at approximately $57.8 million. This acquisition follows Kenvue's better-th", "url": "https://www.marketbeat.com/instant-alerts/filing-calamos-advisors-llc-acquires-651000-shares-of-kenvue-inc-kvue-2026-07-14/", "source_name": "MarketBeat", "published_at": "2026-07-14T08:23:35", "published_display": "14 Jul 2026 08:23", "sentiment": "positive", "sentiment_pct": 63, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Shares Surge After Favorable Court Ruling", "summary": "Kenvue (KVUE) shares rose 5% after a favorable court ruling excluded plaintiffs' expert opinions in a class action lawsuit linking prenatal Tylenol to autism or ADHD. The company plans to seek dismissal of the lawsuits, which could push its stock price to between $23 and $25 per ", "url": "https://www.gurufocus.com/news/8955790/kenvue-kvue-shares-surge-after-favorable-court-ruling?mobile=true%3Fmobile%3Dtrue&mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-14T02:40:35", "published_display": "14 Jul 2026 02:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue options trading climbs to over 16,000 contracts By Investing.com", "summary": "Options trading activity for Kenvue Inc. (KVUE) significantly increased to 16,298 contracts by 11:50 a.m. New York time on Monday. Call options comprised 7,912 contracts, while put options totaled 8,386 contracts. The most active contracts included the July 17, 2026 $19 put and t", "url": "https://au.investing.com/news/stock-market-news/kenvue-options-trading-climbs-to-over-16000-contracts-93CH-4530470", "source_name": "Investing.com Australia", "published_at": "2026-07-14T02:04:00", "published_display": "14 Jul 2026 02:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Second Circuit Court of Appeals Ruling", "summary": "Kenvue Brands LLC, the maker of Tylenol, issued a statement regarding a Second Circuit Court of Appeals procedural ruling on acetaminophen litigation. The company emphasized that independent science shows no proven link between acetaminophen use and autism or ADHD, and highlighte", "url": "https://www.kenvue.com/media/second-circuit-court-of-appeals-ruling", "source_name": "Kenvue", "published_at": "2026-07-13T19:20:23", "published_display": "13 Jul 2026 19:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue's Tylenol Liability Nightmare: Appeals Court Reversal Ignites Fresh Legal Battle", "summary": "A federal appeals court has reinstated hundreds of lawsuits alleging a link between prenatal Tylenol exposure and autism/ADHD, overturning a previous dismissal. This creates significant financial and reputational uncertainty for Kenvue, despite the company's insistence on Tylenol", "url": "https://www.kavout.com/market-lens/kenvue-s-tylenol-liability-nightmare-appeals-court-reversal-ignites-fresh-legal-battle", "source_name": "Kavout | AI", "published_at": "2026-07-13T18:38:13", "published_display": "13 Jul 2026 18:38", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims", "summary": "A federal appeals court has revived over 500 lawsuits against Kenvue, the maker of Tylenol, concerning claims that the painkiller causes autism and ADHD in children when used during pregnancy. The court stated that a district judge improperly excluded expert testimony from three ", "url": "https://www.theglobeandmail.com/business/international-business/us-business/article-us-appeals-court-kenvue-lawsuits-tylenol-autism-claims/", "source_name": "The Globe and Mail", "published_at": "2026-07-13T17:52:28", "published_display": "13 Jul 2026 17:52", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Update: Kenvue Must Face Claims Linking Tylenol to Autism, Appeals Court Says", "summary": "A federal appeals court has ruled that Kenvue, the maker of Tylenol, must face claims in multidistrict litigation alleging a link between prenatal acetaminophen use and autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD). This decision overturns an e", "url": "https://www.moomoo.com/news/post/72874211/update-kenvue-must-face-claims-linking-tylenol-to-autism-appeals?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-13T17:38:35", "published_display": "13 Jul 2026 17:38", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "KVUE Stock Dips After Court Revives Tylenol Autism Lawsuits", "summary": "Kenvue (KVUE) shares dropped after a federal appeals court revived lawsuits alleging Tylenol use during pregnancy increases the risk of autism and ADHD in children. The court overturned parts of a lower court's dismissal, allowing key expert testimonies, though Kenvue maintains e", "url": "https://stocktwits.com/news-articles/markets/equity/kvue-stock-dips-after-court-revives-tylenol-autism-lawsuits/cZmzDliR7Yj", "source_name": "Stocktwits", "published_at": "2026-07-13T17:09:14", "published_display": "13 Jul 2026 17:09", "sentiment": "negative", "sentiment_pct": 29, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Inc. stock falls Monday, underperforms market", "summary": "Kenvue Inc. stock (KVUE) fell 1.28% on Monday, closing at $19.23, which was below the market's performance as both the S&P 500 Index and Dow Jones Industrial Average also declined. The company's stock is now 15.92% below its 52-week high of $22.87.", "url": "https://www.marketwatch.com/data-news/kenvue-inc-stock-falls-monday-underperforms-market-62ffe00f-e973b36d569d", "source_name": "MarketWatch", "published_at": "2026-07-13T16:55:00", "published_display": "13 Jul 2026 16:55", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Must Face Claims Linking Tylenol to Autism, Appeals Court Says", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/kenvue-must-face-claims-linking-154201709.html", "source_name": "MT Newswires", "published_at": "2026-07-13T15:42:01+00:00", "published_display": "13 Jul 2026 15:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Inc. (KVUE) Stock Price | Live Quotes & Charts | NYSE", "summary": "This page provides live quotes and charts for Kenvue Inc. (KVUE) stock, including its current price and daily performance. It also includes sections for analyst ratings and earnings information, although specific data for Kenvue Inc. is noted as unavailable. The page is part of a", "url": "https://www.timothysykes.com/quote/KVUE/", "source_name": "www.timothysykes.com", "published_at": "2026-07-13T15:38:22", "published_display": "13 Jul 2026 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "US appeals court revives private lawsuits linking Tylenol to autism, ADHD", "summary": "A federal appeals court has revived over 500 private lawsuits against Tylenol maker Kenvue, alleging a link between Tylenol use during pregnancy and autism and ADHD in children. The 2nd U.S. Circuit Court of Appeals in Manhattan ruled that a district court judge improperly exclud", "url": "https://www.reuters.com/world/us-appeals-court-revives-private-lawsuits-linking-tylenol-autism-adhd-2026-07-13/", "source_name": "Reuters", "published_at": "2026-07-13T15:38:21", "published_display": "13 Jul 2026 15:38", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock falls after court revives autism lawsuits", "summary": "Kenvue Inc. shares fell 1% after a federal appeals court revived lawsuits alleging Tylenol causes autism in children whose mothers used it during pregnancy. The court overruled a lower court's decision to block cases by excluding expert testimony, remanding it for further proceed", "url": "https://www.investing.com/news/stock-market-news/kenvue-stock-falls-after-court-revives-autism-lawsuits-93CH-4788913", "source_name": "Investing.com", "published_at": "2026-07-13T15:30:21", "published_display": "13 Jul 2026 15:30", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tylenol-Maker Kenvue Must Face Autism Claims, Appeals Court Says", "summary": "A federal appeals court has reinstated lawsuits against Kenvue Inc., the maker of Tylenol, alleging the company concealed risks that the pain reliever could cause autism in children when taken by pregnant mothers. The court ruled that a lower court improperly dismissed the cases ", "url": "https://www.bloomberg.com/news/articles/2026-07-13/tylenol-maker-kenvue-must-face-autism-claims-appeals-court-says?srnd=homepage-europe", "source_name": "Bloomberg", "published_at": "2026-07-13T15:20:00", "published_display": "13 Jul 2026 15:20", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue options trading climbs to over 16,000 contracts", "summary": "Options trading activity for Kenvue Inc. (NYSE:KVUE) surpassed 16,000 contracts by Monday morning, with a near-even split between call and put options. Key activity included the July 17, 2026 $19 put and the July 17, 2026 $20 call, as well as several spread strategies and straddl", "url": "https://www.investing.com/news/stock-market-news/kenvue-options-trading-climbs-to-over-16000-contracts-93CH-4788970", "source_name": "Investing.com", "published_at": "2026-07-13T12:03:00", "published_display": "13 Jul 2026 12:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Listerine Cool Mint by Kenvue Inc. - mouthwash staple under fresh brand owner", "summary": "This article examines Listerine Cool Mint, a flagship product now under Kenvue Inc., detailing its formula, market positioning within the Listerine range, and its transition from Johnson & Johnson. It highlights the mouthwash's contribution to Kenvue's stable revenue stream, cons", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/listerine-cool-mint-by-kenvue-inc-mouthwash-staple-under-fresh-brand/69760042", "source_name": "ad-hoc-news.de", "published_at": "2026-07-13T11:24:21", "published_display": "13 Jul 2026 11:24", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock steadies as investors weigh its consumer brands", "summary": "Kenvue, the maker of Tylenol and other consumer health products, is categorized as a consumer staples company, leading to a more defensive investor profile. The company's diverse portfolio across pain relief, skin health, oral care, and allergy relief means its stock performance ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/kenvue-stock-steadies-as-investors-weigh-its-consumer-brands/69758889", "source_name": "Ad Hoc News", "published_at": "2026-07-13T07:48:23", "published_display": "13 Jul 2026 07:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (NYSE:KVUE) Rating Increased to Buy at Wall Street Zen", "summary": "Kenvue (NYSE:KVUE) has received an upgrade to a \"buy\" rating from Wall Street Zen, though the overall analyst consensus remains a \"Hold\" with an average price target of $19.33. The company's shares are currently trading at $19.50, and its recent earnings exceeded expectations wit", "url": "https://www.marketbeat.com/instant-alerts/kenvue-nysekvue-rating-increased-to-buy-at-wall-street-zen-2026-07-12/", "source_name": "MarketBeat", "published_at": "2026-07-12T17:33:04", "published_display": "12 Jul 2026 17:33", "sentiment": "positive", "sentiment_pct": 65, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Reactions to KVUE Trends in Macro Strategies", "summary": "The article provides a technical analysis of Kenvue Inc. (NASDAQ: KVUE), highlighting conflicting sentiment and suggesting choppy market conditions. It outlines three AI-generated trading strategies\u2014Position, Momentum Breakout, and Risk Hedging\u2014tailored for different risk profile", "url": "https://news.stocktradersdaily.com/news_release/151/Technical_Reactions_to_KVUE_Trends_in_Macro_Strategies_071126105601_1783824962.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-11T23:08:10", "published_display": "11 Jul 2026 23:08", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sumitomo Mitsui Trust Group Inc. Sells 343,749 Shares of Kenvue Inc. $KVUE", "summary": "Sumitomo Mitsui Trust Group Inc. reduced its stake in Kenvue Inc. by 6.6% in the first quarter, selling 343,749 shares, though it still holds over 4.8 million shares valued at $84 million. Other institutional investors showed mixed activity, with some increasing their positions a", "url": "https://www.marketbeat.com/instant-alerts/filing-sumitomo-mitsui-trust-group-inc-sells-343749-shares-of-kenvue-inc-kvue-2026-07-11/", "source_name": "MarketBeat", "published_at": "2026-07-11T14:38:07", "published_display": "11 Jul 2026 14:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Listerine Cool Mint by Kenvue Inc. - mouthwash classic backs broader oral care push", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQcWxvV3JONmxKRWVCRExvNVJpZ1ZNSkQzVnROUGtadklaZ2dxUUpXNWkwWk9VZVhlQmkzcG9hUHF0X0otVlhfOUJ5Rm5nUFpHZWhtWEhDdV8tYmRLX0Vncm91bi14aWVua0FqU3Y5Z0J4eDhfcHcwcldPRXBIcVQxQzRCV1dvVXFrSEFvamlwM2ZZQ0NsX0NiVmphS2hSTHdZNHlUQ29uM2F1NTJpeGUydU1yODF6Q1d1bkdBZ3hTTDNXajZGX1V2bQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-11T05:48:37+00:00", "published_display": "11 Jul 2026 05:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock holds steady as the consumer health story builds", "summary": "Kenvue stock, trading on the NYSE under ISIN US49177J1025, maintains stability due to its strong consumer health portfolio and well-known household brands. Spun off from Johnson & Johnson, the company's revenue is tied to everyday health products, focusing on brand strength, pric", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/kenvue-stock-holds-steady-as-the-consumer-health-story-builds/69741445", "source_name": "ad-hoc-news.de", "published_at": "2026-07-11T06:10:06", "published_display": "11 Jul 2026 06:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue's Hidden Bullish Bet: Options Surge Amidst Acquisition and Mixed Valuation Signals", "summary": "Kenvue (NYSE: KVUE) has shown a significant surge in bullish call options despite its stock largely underperforming the market and maintaining a \"Hold\" consensus from Wall Street analysts. This contrarian interest, combined with its ongoing integration with Kimberly-Clark and a m", "url": "https://www.kavout.com/market-lens/kenvue-s-hidden-bullish-bet-options-surge-amidst-acquisition-and-mixed-valuation-signals", "source_name": "Kavout | AI", "published_at": "2026-07-11T01:38:17", "published_display": "11 Jul 2026 01:38", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Illinois Appellate Court Affirms $45 Million Mesothelioma Verdict Against Johnson & Johnson and Kenvue", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/illinois-appellate-court-affirms-45-203000724.html", "source_name": "Business Wire", "published_at": "2026-07-10T20:30:00+00:00", "published_display": "10 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue focuses on consumer health portfolio as investors track long term growth prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOS25wdzZTZFhwamRnZkpTNG91RG8zSnRUaWlGM001dDhYN1c3NUVtWjJIM1pjVWpmdjM4N0tCb243YXdhdWdFN3JCbHNLbHdpYlhPVU9yNklrWUVmeDh1MUlhY3dnOEhjZUFIenRBUm5MSHBDYk13VzdXQkNFZjJfQVJVaGdJNEtPT21PWXlNcFUyUHV2QU1NMEduU2prQVBlemdNMlFJN3hFZFdWMTZaeGpBWEU5YTNiekJnVWUwVmYzcE5SSnVkVVA4cw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-03T15:57:05+00:00", "published_display": "03 Jul 2026 15:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Stock May Be A Bargain Despite The Acquisition Bid", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNSkhCMTl5RVJkc2lzUGVsc2FGbGVXU2Z5VGpoNWRjc3FBN2dMZTNMWFV5WVhlSW1Yc0hSbGR5bU5Yb0sxUHdRNFZOX3NmWHdiVUNpY2ZNN05KZjdSaENybmNzYTF0d2xsbGEwQUNET0NmMU5hWU9FdHBFaTM3Wm9SVnZjdGtGM2c4OFFocWRNMDQtQjZrMDVLeHN3?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Buy Kenvue Inc. (KVUE)\u2019s Shares?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOUXFueTFqclFBTUFOSFY4Y2NmajVsSG84V2RITEFPRzdjUjBJRWRQR1U4NGFGaXBQSUtYOHBlZ2xnRmtobU1pSkdzTDRqei1qM0poWS0tUU1Wcl9ob25oeTlIOFhfU2gwem9PbkVBalQ2U0xXbDQ0Q2JlX3d0MmxBVnBQM3E5OXczR3BfWGZxOGxvUkNV?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Faces A $48.7 Billion Kimberly Clark Deal And Big Portfolio Questions", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQR1E1dkFZY3VDRk1JbWFfWWR4UkpjX0k1WXk5alp6bTlmTndObE1NWUwwS0t2QkdHMzVUeThycW1sWW1icnFST2twTEV6SUxmN1lXVjBQRjdiLU1uLUFTbWRMZXVYMjUwcE9pYjl3QVF0Tm14MnFCX29KdlpTY1p0YjNDNzUwWVE3NXdHdFFJQVA?oc=5", "source_name": "Market source", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Stock - Weekly outlook with earnings and events ahead", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQbmtfWXEtc2tzU2pmWGFEYW0zeGdDeXlMcjJhc0M2bDY2eVhlMHVOZnJKcXo0aUhHOWF0ZldEOTc3TlJxS0dQRW9YSmhfVElRejlhMVQ2Y2o0d0Z0T01oaThfMUNxclhyVWZQR0NQZ1Y2QzFUMVo2Z2c0R1ZBQUlSSUM4ODZHbTBHUHJIeGZNWGRnSzRTM1IzcnpPekZubjd4c25OeVk5aklpQS01NTdaZU1QVXVLM3RV?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Kenvue (KVUE) Offer Value After Share Price Decline And DCF Upside Projection", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPbWs1SG9sOVY1Rkx1RnowNXdETzg1TDh4dHJMak1wbHZHb3A3S0w4eHpsNENKZVVwdjBqdkt3dlpwZjNwT3pmZVFUSVVEVGhlWi1ETXdhOG5MZUQtWFpDbS1teTJCMFRkQ2c4Vy10cnVnS1lZVlFnZGdlNjhTNzJCRmhJSjhWVlBXNXBXemZZdmI0bVpEZDJYWA?oc=5", "source_name": "Market source", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Stronger Q1 2026 Earnings and Legal Shifts At Kenvue (KVUE) Have Changed Its Investment Story", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock (US49177J1025): Q1 growth accelerates ahead of Kimberly-Clark deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNaW0zSGI5a0NncUd2bnRxYTZ4cW5MbXV0d3BDRjJNRE1sY2tMRnpkZG9fLWlEUmE1REhjNWU4bmF1cExDMDl4TnM0Z0hXei1uSzdvUE5QaU1POGJ4X1M5Ui00ZnR5WWJVeEx4WFFnV2tuMDRvajU5bWpqMHZ6VldjYjNvVm0yeFNMaDlvZ1JtRFI5LS1KWnBFYmp1anp3Q3RlYnBYZ3FBZFhKbGoyR3ZkUFpmNktsNk0yVW5xS1VHRWxfTHhybjlXdF93?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (KVUE) Valuation Check After Mixed Share Price And Earnings Multiple Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQU1dCSlgwWXpHb2xfWVNrRm9MZFQ2ajYwM19WenpmWEx0Zk9iVXg1eDFmNi04b3NTRjZLaGZ6bVdxYTlUVkluc1EwX3lvNWRKbkRzOHdNSkw3cTZ6UFQ0Z0VybzhTREVtSHRPMHF1TEZWYXg5ajhEby0zVGNWZUtickNkbHNWdTFwMm1YT09OSXFNZFlQX1RaMi1KSjBPUG8?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Stock: Is Wall Street Bullish or Bearish?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQeHBiQndHejFjR3I3V2RNMEh1WnhseFkzZkdLdHZicnlUQVJWSmtwT25lcUdZTWxaRW9QZkVqcDdZQkVrNG1ieHF0eDdnek5LOW00Vkw1cmFUbVVRNGZ6aVUyZjQweDhHQmNPaVZ3VHZFcy1mMmEyeHc4ZlZNZGNxZFVVbzF4eGVsam5qTGZuV1YweXd3MVBoSXBrWWNDdw?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Judge rejects Kenvue bid to dismiss Texas lawsuit over Tylenol safety", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPUDF0U3pNNGFzb00yR21PNkhvMFhGNnRwQUpxZ2hVQ2JlUWNmRW1WNE9zZU84NHk2V3dJTDFhM0FHdlRxdUxOQ2dYOFlSWHhhWnpiUS1leEh3RmtCX0ZqdUlkSXBsc2taVjVBMWhHVWNwZUFxQ3pSWnhuQlhMT0FMNU1COThLVHp3Mzk3X3FQaUxHd1ZXTzNQWjZubXdpbjZkWGc4?oc=5", "source_name": "Reuters", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Tops Q4 Earnings Estimates, Advances Toward Kimberly-Clark Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPN3AteHQ0ZVRSdks2NzhfYkVadzFiQWVHeWxUNUFZdHFqanBGblUteUMyX3NMSF9aX3VQejd2ME9lOUJmMkFuS2RuUkY3SnZIS3VuVGluTFM3NFNhYWVJRkdVaEFLZmZ5ZzRjU3dkYzJtbEluMlZGdnlkLU9WZEprbUIxbkgwYzlCNUY4cGhhUEhwRzVQWjdKaVRLbUd0UU92bWdqaTc0NDVnOVFYN0thZldtR1NvSkRzYXE0a29mbkl6SGM?oc=5", "source_name": "TradingView", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue Reports Fourth Quarter and Full Year 2025 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOaHEzWGpiSHBmdnp3VWdCdVFlQlBvUnVVOGQ5UzR2Q013bFRWUDhVUHpiWDJ5ZUFQdkpoXzAwVmV3Z2dMSEZlZVl5akkwZ09adjZjUHloeHU5RXhiQ2J2ZTU5bG1hSEhCbXZOSjB6X3pZVngzU3pUSE9TSXFMNFlUY1NLaTBoNUJkZWMyYXRVSS14eTg1cFRXRVFmZnM5YzQ1dmVKVHZUSWEzWVczZTE4U0hxUQ?oc=5", "source_name": "Business Wire", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (NYSE: KVUE) details 2025 results, $250M restructuring and Kimberly-Clark deal progress", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPQ1RfbmQ2NDhuNzlQaTV5bGhkNDU4ZVpZM3hpemk1TWRjSW9BQ0ltVDVkVGRCMHpvTk5BT0IyemI2VjNIaVlMRTFTQ1NxWEwtOWpDcTdNQ2hZOE9hVXNwajIxbkNwODk4UDZvS2YxbnZvR0t5cU5UT1hhM3NVWEZnUzkyRmVKbEVRMHNMTUlfZGRmU2ZQVVQ3QXpxVkxUdUJw?oc=5", "source_name": "Stock Titan", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Texas judge defers ruling on Kenvue dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOOFpvVTJEYUdmTkVHMlpDTUQ1eGV6dTMwMHlDaVFzQURmQkk4QXNrVVBCOERnSFRpN3VWMHFMdmFsNzdSdFJYekFXVUJ0c0VXaVFDazlXb0JieDduSHFhRE95THVxX1dYWXh1UzYtWHB4ZDlRVlNxbkNDLUNsVUVUblRXbGNUS2hlTDFB?oc=5", "source_name": "Reuters", "published_at": "2025-11-14T08:00:00+00:00", "published_display": "14 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxQQWctaTJQcFEzbWxDX0FLWEdjTDg2a3daMmlWaG1OeWRBRUhka1dwb0dJbHBzZk9HUHpaV3B0ZXRYZFVTc3hxOEVDdkFMZTZCY2Q3WlJ5aWJLdVpZWEVjQk95T1h1UFBfTlRlZEdOWXI2UlFlejFQOFFjT0xvQW9nbEFrS042VHo2VWZJODhVWHdIbUZNVzVWY1FBNWVGVDF2VmQwcW5zS2wwa2xGbkJiTEZOeDQ1ZFFMMHZjeW1WbVdUVVpnSTdqcEFINXR3ZjZNRFZSVVJQTmhvRmNfWVVENEduRVczZWwzMGFLTTNMQVloeU8wVXc?oc=5", "source_name": "Kenvue Investor Relations", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue\u2019s legal risks loom over planned acquisition by Kimberly-Clark", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxORVpKSjZSNlRaVEZObmhqUV9wSm93aUF5bDNNQmd0QnVzaGZUbVlwSnhtQkNZSjBLWmJ6eXNUYmlYTlZERTJfVEdBMDlKMFd5OGtlenZiT3dJNE1fSUl3dTd5dm5DOWRnSVByR0Y3b24xWDcwZkpoZ0YyRFdhNFB4SllFNVBtdXBtVVh5dEtJTjZMRV9YZEo4bTE0Q3VWMV9RcWp6ZjN2dnBna2JabmNteEt2bWpiM1Q0NXliZQ?oc=5", "source_name": "Reuters", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue (NYSE:KVUE) Is Due To Pay A Dividend Of $0.2075", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-01T07:00:00+00:00", "published_display": "01 Nov 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Litigation risks for Kenvue: focus shifts to U.S. appeals court", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOdXlNQUFHeTB5NXFYczAxOWxFN1Nzdm5wM1E0MnpDdFZTT3NIUllGRWUwdFU2dVlwMUl4T2s0S25pWGhaN1BhMjRQcGpvcU5RdkZHV01HaEtPTlpFclo4VEhWZWRua2pmTU96S0xYNHJOWnZpR096dkdnc19fblUxbEk1bjNTUURHRVo2eUk3cjJxZHJ1bkcyelNzLTlCQkJETXd6Qm12Y2piZXNiWTJUUGVlUlJUdXBN?oc=5", "source_name": "Investing.com", "published_at": "2025-10-05T07:00:00+00:00", "published_display": "05 Oct 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tylenol-maker Kenvue shares bounce back, Trump claims face pushback", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPNmhEd3NpMlVhSy1xS2tPNE5uRHdvSmllRmtXU0JIT0p3cG9PWV9Vd1JjR3Z5bjRzeUZYT2ZJbjJTUFZjVU16Z2wxU0djRmlpZVVLWU5Pb3J2amNhZ3kwTU1TdE84VW9COXBxaUFrdmtRcnVUUE5VRGdhVE5SSFBLQ1hFX0s5dEY5bS1RUjNSS1p1WGM3c2JoUndqdWZFMkd3TXE1TEJ2OGNHUUZMUDdYOUFHRWJ0bEExSDVaTXJOZUlHSE02cVNzSjRvUDA1UQ?oc=5", "source_name": "Reuters", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE1HTzdmbHVxeHdNcllfQWpZdWNBaVAyZ3g3V0JZVmJ0cXBzMmFBdWVBbHJzelhCWkxsSXR4ckx0YnVzWDRRNXpBVDhFZjlVWWE3YzBWckZwcFMyTlVvbTZralZHakw0VEJIZ09RM25fcUg0cXl4WjVV?oc=5", "source_name": "The New York Times", "published_at": "2025-09-22T07:00:00+00:00", "published_display": "22 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPR1dRTW1vdXZmcDZXc0o1bVc0NjZCRFo4M1o1aWdwdUhRTjFvYmltOUx3U05aUG9SRGdJZXBTVWJjMndRN3dIU2dRUmxidDg0UEx5VDJwQmFZQ2tvREZuckU4dDc2WnpYWVk3eUhZYU5ZUGFNdnc2c082YkViUmRjU0ZR0gGHAUFVX3lxTE1mT2V1eFVQUWRKUllOVUxIS3lKQ2ppRkxBYnhlTG5EQnJEd29iamRfYmlxZFlDbFdYR3ktbDd5MEhpT2lzVkpZY18yR2ZJLUI3ZjdhTGNzYmtSQUxENy02QUJzbHRpOWtrX1VxM2NBbjAtVzFuQXdqajcwSGtrYUpkX2Z3TUhoSQ?oc=5", "source_name": "CNBC", "published_at": "2025-09-05T07:00:00+00:00", "published_display": "05 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Wary Of Buying Kenvue's (NYSE:KVUE) For Its Upcoming Dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-09T07:00:00+00:00", "published_display": "09 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 109, "total_relevant": 52, "sentiment_summary": {"positive": 10, "negative": 13, "neutral": 29, "score": 45, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 73, "events": [{"event": "general", "label": "Market update", "weight": 11.85, "count": 19}, {"event": "earnings", "label": "Earnings", "weight": 6.6, "count": 12}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 6.0, "count": 9}, {"event": "deals", "label": "Deals and strategy", "weight": 4.2, "count": 7}, {"event": "capital_return", "label": "Capital return", "weight": 2.0, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 13}, "market_context": {"has_market_context": true, "latest_close": 19.48, "latest_week": "2026-07-10", "one_week_move": -1.8, "four_week_move": 7.4, "twelve_week_move": 12.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.219256, "market_dynamics_buy_signal": false, "relative_strength": -0.93553, "fair_value_gap": 2.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 48.2531, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.8% over one week, +7.4% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MarketBeat", "count": 6}, {"label": "Market source", "count": 6}, {"label": "Reuters", "count": 5}, {"label": "Ad Hoc News", "count": 5}, {"label": "simplywall.st", "count": 4}, {"label": "Investing.com", "count": 3}, {"label": "MarketWatch", "count": 2}, {"label": "Kavout | AI", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 19}, {"label": "Earnings", "count": 12}, {"label": "Regulatory and legal", "count": 9}, {"label": "Deals and strategy", "count": 7}, {"label": "Capital return", "count": 3}, {"label": "Analyst action", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "45/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "73/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "9", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.8% over one week, +7.4% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Diversify Wealth Management LLC Buys New Stake in Kenvue Inc. $KVUE"}], "updated_at": "2026-07-16T10:53:38.896958+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}